{
    "title": "AbbVie's 2023 profit forecast misses as Humira faces heat from rivals",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11731691/AbbVies-2023-profit-forecast-misses-Humira-faces-heat-rivals.html",
    "date": "2023-02-09",
    "keywords": [
        "share",
        "humira",
        "competition",
        "year",
        "inc",
        "forecast",
        "profit",
        "blockbuster",
        "drug",
        "market",
        "growth",
        "quarter",
        "thursday",
        "street",
        "outlook",
        "arthritis",
        "company",
        "range",
        "estimate",
        "pace",
        "discount",
        "price",
        "summer",
        "list",
        "driver",
        "health",
        "insurance",
        "coverage",
        "europe",
        "line",
        "abbvie",
        "cliff",
        "patent",
        "expiry",
        "deal",
        "botoxmaker",
        "drugmaker",
        "immunology",
        "skyrizi",
        "rinvoq",
        "revenue",
        "beat",
        "reporting",
        "mariam",
        "e",
        "sunny",
        "leo",
        "bengaluru",
        "editing",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}